Business
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
BRISBANE, Calif., February 24, 2026--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company’s Chief Operating Officer (COO), will also assume the responsibilities of Chief Financial Officer (CFO) and oversee the Company’s finance organization effective
About this update from Caredx, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/0923ccb94f97229cf42f9d3d2d2f24f8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xXbWsf28zwcKwMeSoyccOg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0923ccb94f97229cf42f9d3d2d2f24f8","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wduAQ9gBrgN8saJqQTcLMA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/0923ccb94f97229cf42f9d3d2d2f24f8","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Kennedy brings seven years of public company CFO experience","length":59,"tagName":"p"},{"type":"text","content":"BRISBANE, Calif., February 24, 2026--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company’s Chief Operating Officer (COO), will also assume the responsibilities of Chief Financial Officer (CFO) and oversee the Company’s finance organization effective February 26, 2026.","length":536,"tagName":"p"},{"type":"text","content":"Kennedy brings to CareDx over 20 years of experience and executive leadership in healthcare including global diagnostics, biopharma services, and contract development and manufacturing organization (CDMO). Kennedy has served as our Chief Operating Officer since September 2024. Prior to joining us, Kennedy served as CFO at PharmaLogic Holdings Corp from April 2022 to September 2024. At Veracyte, Kennedy served in various roles from December 2016 to May 2021, including as COO, CFO, and Secretary. Kennedy also held key executive positions at MCG Capital Corporation and GE Capital. He served as an Officer in the U.S. Air Force. Kennedy received a B.S. in Accounting with high distinction from Indiana University and an M.B.A. from the College of William & Mary. Kennedy is a Chartered Financial Analyst and Certified Public Accountant.","length":843,"tagName":"p"},{"type":"text","content":"Nathan Smith announce...